Nabla
PrivateLast Round
Series C
Jun 17, 2025
Est. Valuation
$180M
Total Funding Raised
$114.3M
Momentum Score
50 /100
Company Overview
Nabla is a healthcare technology company that offers an AI-driven machine learning platform to identify personalized health trends, facilitate communication with practitioners, centralize medical data, and generate clinical notes swiftly, ultimately enhancing patient care and outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Workflow Automation, EHR & EMR, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nabla Comps
Public and private peers based on sector, stage, and business model.
Nabla Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2025 | ||||
| Series B | Jan 5, 2024 | ||||
| Early Funding | Apr 7, 2021 |
Key People
Founding team and executive leadership
Nabla Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series C |
| HV Capital | Series C |
| DST Global | Series C |
| Firstminute Capital | Early Funding |
| Build Collective | Series C |
| Artemis | Early Funding |
| ZEBOX Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
Dr. Matt Sakumoto appointed as Chief Clinical Product Officer.
- Feb 8, 2026
Added Aultman Medical Group, an enterprise healthcare company, as a customer.
Nabla Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nabla's valuation, stock price, and market status.
